FY2025 EPS Estimate for Ascend Wellness Decreased by Analyst

Ascend Wellness Holdings, Inc. (OTC:AAWH) – Equities researchers at Cormark lowered their FY2025 earnings per share (EPS) estimates for Ascend Wellness in a research report issued on Wednesday, November 12th. Cormark analyst J. Pytlak now anticipates that the company will post earnings per share of ($0.46) for the year, down from their prior forecast of ($0.44). The consensus estimate for Ascend Wellness’ current full-year earnings is ($0.40) per share.

Separately, Zacks Research upgraded shares of Ascend Wellness from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Ascend Wellness Price Performance

Ascend Wellness stock opened at $0.55 on Friday. Ascend Wellness has a 52 week low of $0.26 and a 52 week high of $0.98. The company has a quick ratio of 0.80, a current ratio of 1.47 and a debt-to-equity ratio of 2.61. The firm’s 50-day simple moving average is $0.74 and its 200 day simple moving average is $0.54. The firm has a market capitalization of $112.44 million, a PE ratio of -1.34 and a beta of 1.12.

About Ascend Wellness

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands.